Skip to content

Author

M. Algeri

We have 2 of 138 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Abatacept in combination with ATLG reduces acute GvHD incidence and improves outcomes of children transplanted from mismatched unrelated donors: a real-world, multicenter, retrospective study.

BACKGROUND The use of HLA-mismatched donors has been associated with increased risk of both acute and chronic Graft versus Host Disease (GvHD). The use of abatacept (ABA) reduces the risk of acute GvHD. ABA data in pediatric patients and in combination with serotherapy are limited. OBJECTIVE We hypothesized that addi...

F. Quagliarella, Matteo Becci, Jochen Buechner et al. · 1 citation
Review Open access Aug 2026

2026 Update on Clinical Trials in β-Thalassemia.

Several promising approaches targeting fetal hemoglobin induction, iron metabolism, and ineffective erythropoiesis have failed to demonstrate sufficient clinical benefit despite preclinical proof of concept, highlighting the complexity of therapeutic development in β-thalassemia.

K. M. Musallam, F. Locatelli, M. Algeri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.